Capsule endoscopy is a minimally invasive technique that uses a wireless camera to capture images of the gastrointestinal tract. The images are transmitted to a recorder device worn by the patient and can be viewed by a physician later. Capsule endoscopy is mainly used to diagnose diseases and disorders of the small intestine, such as bleeding, tumors, polyps, inflammation, ulcers, and malabsorption. It can also be used to examine the esophagus and the colon, but with less accuracy and coverage than other endoscopic methods.
The capsule endoscopy market was valued at USD 959.6 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2032, reaching USD 2033.10 million by 2032. The growth of the market is driven by the increasing prevalence of gastrointestinal diseases, the rising geriatric population, the growing demand for minimally invasive procedures, the technological advancements in capsule endoscopy devices and the favorable reimbursement policies in some regions. However, the market is also constrained by the high cost of capsule endoscopy, the limited availability of skilled professionals, the risk of capsule retention, and the lack of awareness and acceptance among patients and physicians in some regions.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/capsule-endoscopy-market/requestsample
Key Drivers and Constraints
- The increasing prevalence of gastrointestinal diseases, such as inflammatory bowel disease, Crohn’s disease, celiac disease, gastrointestinal bleeding, small bowel tumors and obscure gastrointestinal bleeding, is one of the major factors driving the growth of the capsule endoscopy market. According to the World Health Organization (WHO), more than 60 million people suffer from inflammatory bowel disease worldwide, and the incidence and prevalence are rising in many regions. Capsule endoscopy is an effective and non-invasive tool to diagnose and monitor these conditions, especially in the small intestine, where conventional endoscopy and colonoscopy cannot reach.
- The rising geriatric population is another key driver of the capsule endoscopy market, as older people are more prone to develop gastrointestinal disorders and complications. According to the United Nations, the global population aged 60 years and over is projected to reach 2.1 billion by 2050. The aging population will increase the demand for capsule endoscopy, as it is a safer and more comfortable alternative to other endoscopic methods that require sedation, anesthesia and hospitalization.
- The growing demand for minimally invasive procedures is also fueling the growth of the capsule endoscopy market, as patients and physicians prefer less invasive and less painful methods of diagnosis and treatment. Capsule endoscopy offers several advantages over other endoscopic techniques, such as no need for sedation, anesthesia or hospitalization, no risk of infection or perforation, no discomfort or pain, no interference with normal activities and better patient compliance and satisfaction.
- The technological advancements in capsule endoscopy devices are also contributing to the growth of the market, as they enhance the performance, functionality and usability of the devices. Some of the recent innovations in capsule endoscopy include longer battery life, higher resolution, faster frame rate, larger memory capacity, adjustable illumination, magnetic and remote control, real-time video transmission, artificial intelligence and machine learning, and multi-sensor and multi-modal capabilities. These features improve the image quality, diagnostic accuracy, patient convenience and clinical efficiency of capsule endoscopy.
- The favorable reimbursement policies in some regions are also supporting the growth of the capsule endoscopy market, as they reduce the financial burden on the patients and increase the accessibility and affordability of the procedure. For instance, in the United States, Medicare covers capsule endoscopy for the diagnosis of small bowel bleeding and Crohn’s disease, and some private insurers also cover the procedure for other indications. In Europe, some countries, such as Germany, France, Italy and Spain, also provide reimbursement for capsule endoscopy under certain conditions and criteria.
- However, the high cost of capsule endoscopy is one of the major factors restraining the growth of the market, as it limits the adoption and penetration of the procedure in some regions, especially in the developing and underdeveloped countries. The cost of capsule endoscopy is higher than other endoscopic methods, such as gastroscopy, colonoscopy and enteroscopy, which are more widely available and affordable in many regions.
- The limited availability of skilled professionals is another key constraint of the capsule endoscopy market, as it affects the quality and efficiency of the procedure and the interpretation of the results. Capsule endoscopy requires specialized training and expertise to perform the procedure, analyze the images and diagnose the conditions. However, there is a shortage of qualified and experienced capsule endoscopists in some regions, especially in the rural and remote areas, where the access to healthcare facilities and services is limited.
- The risk of capsule retention is also a potential challenge for the capsule endoscopy market, as it can cause serious complications and require surgical intervention. Capsule retention is defined as the failure of the capsule to exit the gastrointestinal tract within two weeks after ingestion. The incidence of capsule retention is higher in patients with known or suspected intestinal strictures, obstructions, fistulas or diverticula. Capsule retention can cause symptoms such as abdominal pain, nausea, vomiting, fever and intestinal bleeding, and can lead to bowel perforation, obstruction, infection or necrosis.
- The lack of awareness and acceptance among patients and physicians in some regions is also a limiting factor for the capsule endoscopy market, as it hinders the adoption and utilization of the procedure. Some patients and physicians may not be aware of the benefits and indications of capsule endoscopy, or may have misconceptions and doubts about the safety and efficacy of the procedure. Some patients may also have difficulty swallowing the capsule, or may have religious or cultural objections to the procedure. Some physicians may also prefer other endoscopic methods that are more familiar and conventional, or may have limited access to capsule endoscopy devices and services.
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/capsule-endoscopy-market
Key Trends and Developments
| Trend/Development | Description | Examples |
| Adoption of AI and ML | Increasing adoption of artificial intelligence and machine learning to enhance image analysis and diagnosis of capsule endoscopy | NaviCam by Ankon Technologies, OMOM by Jinshan Science and Technology, EndoCapsule by Olympus, PillCam by Medtronic |
| Multi-sensor and multi-modal devices | Emergence of multi-sensor and multi-modal capsule endoscopy devices that can provide more comprehensive and detailed information about the gastrointestinal tract | SmartPill by Medtronic, MiroCam by IntroMedic, Sonopill by University of Glasgow, NEMO by University of Leeds |
| Expansion of indications and applications | Expansion of the indications and applications of capsule endoscopy beyond the small intestine to other parts of the gastrointestinal tract, such as the esophagus and the colon | PillCam ESO, PillCam COLON, CapsoCam Plus by CapsoVision |
Market Segmentation
The global capsule endoscopy market can be segmented by product, type, component, application, end user and region.
| Market Segment | Sub-Categories/Description |
| Product | – Small Bowel Capsule: Specifically designed for examining the small intestine. – Colon Capsule: Focused on colon examination and diagnostics. – Esophageal Capsule: Tailored for esophageal inspection and analysis. |
| Type | – Wireless Capsule Endoscopy: Utilizes wireless technology to transmit images. – Receiver Capsule Endoscopy: Involves the use of a receiver to capture data from the capsule. – Others: Includes additional capsule endoscopy technologies not specified. |
| Component | – Camera Capsule: The primary component that travels through the GI tract, capturing images. – Workstation: Used for data analysis and image processing. – Data Recorder: Records the data transmitted by the capsule for later analysis. |
| Application | – Intestine Disease, Crohn’s Disease, Gastrointestinal Bleeding, Tumours, and Others: Highlights the broad range of gastrointestinal conditions that capsule endoscopy can help diagnose. |
| End User | – Hospitals, Diagnostic Laboratories, Ambulatory Surgery Centres, and Others: Indicates the diverse healthcare settings where capsule endoscopy is utilized for diagnostic purposes. |
| Region | – North America, Europe, Asia Pacific, Latin America, Middle East and Africa: Reflects the global distribution and demand for capsule endoscopy, underlining the importance of this technology in gastrointestinal diagnostics across different healthcare systems worldwide. |
This table provides a comprehensive overview of the global capsule endoscopy market.
Competitive Landscape
The global capsule endoscopy market is highly competitive and fragmented, with the presence of several local and global players. The major players in the market are Medtronic, Olympus, CapsoVision, IntroMedic, Check-Cap, Ankon Technologies, Jinshan Science and Technology, RF Co., Ltd. and Shanghai Aohua Photoelectricity Endoscope Co., Ltd. These players compete on the basis of product innovation, quality, price, features, performance, distribution, service and support. They also engage in strategic alliances, partnerships, mergers and acquisitions, joint ventures, collaborations and expansions to enhance their market position and gain a competitive edge.
Some of the recent company news and developments in the capsule endoscopy market are as follows:
| Month | Company | Product | Regulatory Approval | Indication | Features |
| March 2020 | Medtronic | PillCam COLON 2 system | U.S. Food and Drug Administration (FDA) clearance in November 2019 | Patients who have an incomplete colonoscopy or are unable to undergo a colonoscopy | Wireless camera, longer battery life, higher resolution, faster frame rate, larger memory capacity |
| February 2020 | Olympus | EndoCapsule 10 system | CE mark in January 2020 | Patients who have suspected or confirmed small bowel disorders | Wireless camera, longer battery life, higher resolution, faster frame rate, larger memory capacity, artificial intelligence, machine learning |
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
